Ranking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction

• URL: http://arxiv.org/abs/2012.02840v2
• Date: Tue, 8 Dec 2020 04:18:20 GMT
• Title: Ranking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction
• Authors: Ziqi Chen, Martin Renqiang Min and Xia Ning
• Abstract summary: identifying peptides that can bind to MHC class-I molecules plays a vital role in the design of peptide vaccines. We develop two allele-specific CNN-based methods named ConvM and SpConvM to tackle the binding prediction problem.
• Score: 15.932922003001034
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: T-cell receptors can recognize foreign peptides bound to major histocompatibility complex (MHC) class-I proteins, and thus trigger the adaptive immune response. Therefore, identifying peptides that can bind to MHC class-I molecules plays a vital role in the design of peptide vaccines. Many computational methods, for example, the state-of-the-art allele-specific method MHCflurry, have been developed to predict the binding affinities between peptides and MHC molecules. In this manuscript, we develop two allele-specific Convolutional Neural Network (CNN)-based methods named ConvM and SpConvM to tackle the binding prediction problem. Specifically, we formulate the problem as to optimize the rankings of peptide-MHC bindings via ranking-based learning objectives. Such optimization is more robust and tolerant to the measurement inaccuracy of binding affinities, and therefore enables more accurate prioritization of binding peptides. In addition, we develop a new position encoding method in ConvM and SpConvM to better identify the most important amino acids for the binding events. Our experimental results demonstrate that our models significantly outperform the state-of-the-art methods including MHCflurry with an average percentage improvement of 6.70% on AUC and 17.10% on ROC5 across 128 alleles.

Related papers

• NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics [58.03989832372747]
  We present the first unified benchmark NovoBench for emphde novo peptide sequencing. It comprises diverse mass spectrum data, integrated models, and comprehensive evaluation metrics. Recent methods, including DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo and $pi$-HelixNovo are integrated into our framework.
  arXiv  Detail & Related papers  (2024-06-16T08:23:21Z)
• AdaNovo: Adaptive \emph{De Novo} Peptide Sequencing with Conditional Mutual Information [46.23980841020632]
  We propose AdaNovo, a novel framework that calculates conditional mutual information (CMI) between the spectrum and each amino acid/peptide. AdaNovo excels in identifying amino acids with post-translational modifications (PTMs) and exhibits robustness against data noise.
  arXiv  Detail & Related papers  (2024-03-09T11:54:58Z)
• MATE-Pred: Multimodal Attention-based TCR-Epitope interaction Predictor [1.933856957193398]
  An accurate binding prediction between T-cell receptors ands contributes decisively to successful immunotherapy strategies. Here, we propose a highly reliable novel method, MATE-Pred, that performs attention-based prediction of T-cell receptors and affinitys binding regimes. The performance of MATE-Pred projects its potential application in drug discovery.
  arXiv  Detail & Related papers  (2023-12-05T11:30:00Z)
• Efficient Prediction of Peptide Self-assembly through Sequential and Graphical Encoding [57.89530563948755]
  This work provides a benchmark analysis of peptide encoding with advanced deep learning models. It serves as a guide for a wide range of peptide-related predictions such as isoelectric points, hydration free energy, etc.
  arXiv  Detail & Related papers  (2023-07-17T00:43:33Z)
• State-specific protein-ligand complex structure prediction with a multi-scale deep generative model [68.28309982199902]
  We present NeuralPLexer, a computational approach that can directly predict protein-ligand complex structures. Our study suggests that a data-driven approach can capture the structural cooperativity between proteins and small molecules, showing promise in accelerating the design of enzymes, drug molecules, and beyond.
  arXiv  Detail & Related papers  (2022-09-30T01:46:38Z)
• From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph-Based Deep Learning [40.83037811977803]
  Dynaformer is a graph-based deep learning model developed to predict protein-ligand binding affinities. It exhibits state-of-the-art scoring and ranking power on the CASF-2016 benchmark dataset. In a virtual screening on heat shock protein 90 (HSP90), 20 candidates are identified and their binding affinities are experimentally validated.
  arXiv  Detail & Related papers  (2022-08-19T14:55:12Z)
• Attention-aware contrastive learning for predicting T cell receptor-antigen binding specificity [7.365824008999903]
  It has been verified that only a small fraction of the neoantigens presented by MHC class I molecules on the cell surface can elicit T cells. We propose an attentive-mask contrastive learning model, ATMTCR, for inferring TCR-antigen binding specificity.
  arXiv  Detail & Related papers  (2022-05-17T10:53:32Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.